Lykan Bioscience names new president and chief operating officer
5 January 2021 -

Lykan Bioscience, a contract Manufacturing Services Organisation and provider of an end-to-end solution for cell-based therapies, has named Patrick Lucy as its new president and chief operating officer, it was reported on Monday.

Lucy has over 29 years of experience in the biotechnology industry including operations to corporate development. He has served as founder and chief business officer of Pfenex and in various positions at Repligen Corporation, Celltech Biologics, Lonza Biologics and Collaborative BioAlliance.

Lykan Bioscience CEO, Anthony Rotunno, said, 'Patrick's background and expertise aligns well with Lykan's Mission, to partner with our clients to maximise patient accessibility and expedite time to market for cell-based therapies. We are thrilled to welcome Patrick to the team and look forward to his contribution to the future success and continued growth of the company.'